These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7089530)

  • 21. Effects of flavonoids on the metabolism of xenobiotics.
    Wood AW; Smith DS; Chang RL; Huang MT; Conney AH
    Prog Clin Biol Res; 1986; 213():195-210. PubMed ID: 3520588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species differences in benzene hydroxylation to phenol by pulmonary and hepatic microsomes.
    Harper C; Drew RT; Fouts JR
    Drug Metab Dispos; 1975; 3(5):381-8. PubMed ID: 241619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hexachlorobenzene on liver porphyrin levels and microsomal enzymes in the rat.
    Grant DL; Iverson F; Hatina GV; Villeneuve DC
    Environ Physiol Biochem; 1974; 4(4):159-65. PubMed ID: 4459128
    [No Abstract]   [Full Text] [Related]  

  • 24. Substrate interaction with P-450 in the hydroxylation of drugs under abnormal physiological states.
    Kato R
    Adv Cytopharmacol; 1971 May; 1():249-55. PubMed ID: 5163246
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of bioflavonoids on hepatic P450 activities.
    Obermeier MT; White RE; Yang CS
    Xenobiotica; 1995 Jun; 25(6):575-84. PubMed ID: 7483658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the metabolism of vitamin D2 and vitamin D3 by subcellular fractions from rat liver.
    Holmberg I
    Biochim Biophys Acta; 1984 Jul; 800(1):106-9. PubMed ID: 6331517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of benzopyrone derivatives on drug activity and metabolism.
    Kourounakis P; Rekka E
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):269-73. PubMed ID: 3582421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline.
    Murray M
    Mol Pharmacol; 1992 Nov; 42(5):931-8. PubMed ID: 1435757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic and metabolic studies with deuterated zoxazolamine.
    Tanabe M; Tagg J; Yasuda D; LeValley SE; Mitoma C
    J Med Chem; 1970 Jan; 13(1):30-2. PubMed ID: 5412111
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of betamethasone on the in vitro and in vivo 2-hydroxylation of biphenyl in the rat.
    Miller MS; Huang MT; Williams GM; Jeffrey AM; Conney AH
    Drug Metab Dispos; 1983; 11(6):556-61. PubMed ID: 6140139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of p-amino-diphenyl ethers on hepatic microsomal cytochrome P450.
    Jiang H; Xuan G
    Pharmazie; 2003 Sep; 58(9):654-6. PubMed ID: 14531464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo modulation of the rat cytochrome P450 1A1 by double-stranded phosphorothioate oligodeoxynucleotides.
    Tracewell W; Desjardins J; Iversen P
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):179-84. PubMed ID: 8545825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the hydroxylation of zoxazolamine and benzo[a]pyrene in human placenta: effect of cigarette smoking.
    Kapitulnik J; Levin W; Poppers PJ; Tomaszewski JE; Jerina DM; Conney AH
    Clin Pharmacol Ther; 1976 Nov; 20(5):557-64. PubMed ID: 975727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The In vitro hepatic metabolism of quinine in mice, rats and dogs: comparison with human liver microsomes.
    Zhao XJ; Ishizaki T
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1168-76. PubMed ID: 9399990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adaptation to the inhibitory effect of carbon monoxide inhalation on drug metabolism.
    Montgomery MR; Rubin RJ
    J Appl Physiol; 1973 Nov; 35(5):601-7. PubMed ID: 4770343
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.
    Jayyosi Z; Villoutreix J; Ziegler JM; Batt AM; De Maack F; Siest G; Thomas PE
    Drug Metab Dispos; 1993; 21(5):939-45. PubMed ID: 7902259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
    Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of species-difference in microsomal metabolism of amitriptyline using a predictive MRM-IDA-EPI method.
    Lee JY; Lee SY; Lee K; Oh SJ; Kim SK
    Chem Biol Interact; 2015 Mar; 229():109-18. PubMed ID: 25623954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450.
    Veronese ME; McManus ME; Laupattarakasem P; Miners JO; Birkett DJ
    Drug Metab Dispos; 1990; 18(3):356-61. PubMed ID: 1974199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of size and timing of a pretreatment dose of phenobarbitone on the liver lesion caused by ngaione in the mouse.
    Lee JS; Hrdlicka J; Seawright AA
    J Pathol; 1979 Mar; 127(3):121-7. PubMed ID: 469637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.